To consider and approve Unaudited Financial Results for quarter ended 30th June, 2026
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 29 Jul 2026, 02:21 PM IST · BSE ID: c6baf0f9-f29b-4580-b179-6650158b8c9f
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved its financial results for the first quarter, showing INR 28,577.50 lakh in revenue from operations.
🤖 AI Summary
- Sharda Cropchem Board approved unaudited standalone and consolidated financial results for Q1 FY27.
- Standalone revenue from operations for the quarter ended June 30, 2026, was INR 28,577.50 lakh.
- Total standalone income for the quarter reached INR 29,195.47 lakh, per the filing.
- Standalone profit before tax was INR 19,065.73 lakh for the quarter ended June 30, 2026.
- Auditors issued an unmodified limited review report on the standalone financial results.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from Operations (Q1 FY27)
INR 28,577.50 lakh
Standalone Other Income (Q1 FY27)
INR 617.97 lakh
Standalone Total Income (Q1 FY27)
INR 29,195.47 lakh
Standalone Profit Before Tax (Q1 FY27)
INR 19,065.73 lakh
🏢 How This Affects the Company
The Q1 FY27 standalone revenue from operations was INR 28,577.50 lakh. Standalone profit before tax was INR 19,065.73 lakh for the quarter.
👥 What This Means For Shareholders
✅
Action Required
No action required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are informed of the company's standalone financial performance for the quarter ended June 30, 2026, as per the approved results.
🔍
Management Signal
The Board's approval of the unaudited financial results signals regular compliance with financial reporting obligations.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 unaudited results — check for sustained revenue performance.
Future board meeting outcomes — monitor for additional corporate actions.
Analyst calls or presentations — observe management commentary on results.
LOW RISK
The filing is a routine financial disclosure; no new specific risks are introduced.
💡 Investor Takeaway
Sharda Cropchem's Q1 FY27 standalone revenue from operations was INR 28,577.50 lakh. Total standalone income was INR 29,195.47 lakh, with standalone profit before tax at INR 19,065.73 lakh. These unaudited results were approved by the Board.
⚖️ Strengths & Concerns
✅ Positives
- Standalone revenue from operations for the quarter ended June 30, 2026, was reported at INR 28,577.50 lakh.
- Standalone profit before tax for the quarter ended June 30, 2026, stood at INR 19,065.73 lakh.
⚠️ Concerns
- The filing does not provide comparable consolidated financial results data for the prior year's quarter.
- The limited review report notes that Q4 FY26 figures are balancing figures not fully audited in prior interim periods.
📅 Company Track Record
Sharda Cropchem's FY26 audited PAT doubled to Rs. 681 crores, with revenue up 22%. The Board also recommended a Rs. 9.00 per share final dividend for FY26 in May 2026. This filing presents Q1 FY27 unaudited results.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Sharda Cropchem's standalone revenue from operations for the quarter ended June 30, 2026?
Sharda Cropchem's standalone revenue from operations for the quarter ended June 30, 2026, was INR 28,577.50 lakh.
What was Sharda Cropchem's total standalone income for Q1 FY27?
The total standalone income for Sharda Cropchem for the quarter ended June 30, 2026, was INR 29,195.47 lakh.
What was Sharda Cropchem's standalone profit before tax for the quarter ended June 30, 2026?
Sharda Cropchem's standalone profit before tax for the quarter ended June 30, 2026, was INR 19,065.73 lakh.
Did the auditors provide an unmodified opinion on Sharda Cropchem's Q1 FY27 standalone results?
Yes, the auditors, B S R & Co. LLP, provided an unmodified limited review opinion on Sharda Cropchem's unaudited standalone financial results for the quarter ended June 30, 2026.
Questions based on this BSE filing only. For information purposes.